Pharmachal Health Group Apply for SSX Listing

"The new version of the SSX provides an excellent opportunity for an initial listing before we progress onto a major international exchange."

This article is from Various Projects for Health Care, Medical & Biotech

"Pharmachal Health Group are a Melbourne-based pharmaceutical company with a globally-patented, mini-emulsion, drug-in-oil delivery system capable of delivering a wide range of small-molecule APIs (drugs). The technology is called the Nano Drug Delivery System (“NDDS”). Pharmachal's product range includes topical creams and nutritional products, including the breakthrough mini-emulsion lidocaine spray “NOPAYNE”, for which clinical trials were successfully completed under the supervision of world-renowned burns doctor Professor Fiona Wood AO.

Charles Fridlender, Founder and Executive Director said" The new version of the SSX provides an excellent opportunity for an initial listing before we progress onto a major international exchange. We also see early, cost-effective access into exchanges in Germany, USA and the UK as potentially very useful. As a fast-growing company we want to direct as much attention and funds into our international product rollout and don’t need the costs or burden of excessive compliance of a major exchange just yet.  The SSX has the right balance between ensuring compliance and letting businesses do business.”

Phamachal products are based on rigorous research and exacting attention to detail. The company prides itself on producing products that work and solve real health problems."

Contact us for more information about Pharmachal.